We are live on ! Find out more
BDS

Banco de Sabadell Portfolio holdings

AUM $170M
1-Year Est. Return 26.61%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+26.61%
3 Year Est. Return
+75.08%
5 Year Est. Return
+103.03%
10 Year Est. Return
AUM
$132M
AUM Growth
+$16.5M
Cap. Flow
+$4.35M
Cap. Flow %
3.3%
Top 10 Hldgs %
31.17%
Holding
85
New
3
Increased
30
Reduced
46
Closed
3

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.13M
2
ASML icon
ASML
ASML
+$2.08M
3
BDX icon
Becton Dickinson
BDX
+$1.49M
4
PFE icon
Pfizer
PFE
+$1.05M
5
KO icon
Coca-Cola
KO
+$336K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$823K
2
BAX icon
Baxter International
BAX
+$599K
3
SYY icon
Sysco
SYY
+$584K
4
AAPL icon
Apple
AAPL
+$583K
5
TXN icon
Texas Instruments
TXN
+$304K

Sector Composition

Rank Sector Weight
1 Technology 25.55%
2 Healthcare 17.67%
3 Consumer Staples 11.12%
4 Financials 10.61%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$191B
$2.15M 1.63%
7,261
+124
+2% +$33.7K
TJX icon
27
TJX Companies
TJX
$174B
$2.14M 1.63%
22,848
+638
+3% +$57.2K
UNP icon
28
Union Pacific
UNP
$176B
$2.14M 1.62%
8,696
-647
-7% -$142K
NEE icon
29
NextEra Energy
NEE
$182B
$2.13M 1.62%
35,146
+4,540
+15% +$259K
ADI icon
30
Analog Devices
ADI
$185B
$2.1M 1.6%
10,584
-279
-3% -$49.8K
PG icon
31
Procter & Gamble
PG
$345B
$2.08M 1.58%
14,198
-50
-0.4% -$7.41K
MDT icon
32
Medtronic
MDT
$110B
$2.08M 1.58%
25,255
+966
+4% +$73.6K
JNJ icon
33
Johnson & Johnson
JNJ
$614B
$2.08M 1.57%
13,222
-530
-4% -$81.3K
SBUX icon
34
Starbucks
SBUX
$120B
$2.07M 1.57%
21,603
+3,170
+17% +$309K
QCOM icon
35
Qualcomm
QCOM
$171B
$2.07M 1.57%
14,316
+711
+5% +$88.1K
PFE icon
36
Pfizer
PFE
$145B
$2.06M 1.57%
71,860
+34,845
+94% +$1.05M
VLO icon
37
Valero Energy
VLO
$88.9B
$2.01M 1.53%
15,450
+537
+4% +$68.3K
PEP icon
38
PepsiCo
PEP
$190B
$1.97M 1.49%
11,587
+399
+4% +$66.2K
CSCO icon
39
Cisco
CSCO
$480B
$1.97M 1.49%
38,963
+1,548
+4% +$79.1K
SYK icon
40
Stryker
SYK
$129B
$1.92M 1.46%
6,426
+259
+4% +$72.7K
NKE icon
41
Nike
NKE
$61.6B
$1.82M 1.38%
16,822
+720
+4% +$77.4K
DIS icon
42
Walt Disney
DIS
$170B
$1.58M 1.2%
17,524
-117
-0.7% -$10.3K
SAP icon
43
SAP
SAP
$226B
$1.52M 1.16%
9,875
-32
-0.3% -$4.63K
BDX icon
44
Becton Dickinson
BDX
$46.9B
$1.48M 1.12%
+6,063
New +$1.49M
PRU icon
45
Prudential Financial
PRU
$42.9B
$1.32M 1%
12,714
+683
+6% +$65.5K
TXN icon
46
Texas Instruments
TXN
$259B
$1.14M 0.87%
6,710
-1,962
-23% -$304K
SYY icon
47
Sysco
SYY
$39.6B
$1.08M 0.82%
14,768
-8,462
-36% -$584K
RELX icon
48
RELX
RELX
$64.2B
$1.02M 0.77%
25,609
-66
-0.3% -$2.43K
SNY icon
49
Sanofi
SNY
$102B
$985K 0.75%
19,791
+4,083
+26% +$200K
ABB
50
DELISTED
ABB Ltd
ABB
$979K 0.74%
22,052
-58
-0.3% -$2.58K

Similar funds

Banco de Sabadell's Q4 2023 Portfolio in Review

As of Q4 2023, Banco de Sabadell held 85 positions worth $132M, up 14% from $115M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Banco de Sabadell deployed $4.35M of net new capital in Q4 2023, opening 3 new positions and adding to 30 existing holdings. Its largest new stake was Amgen: 7,816 shares worth $2.25M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Microsoft, an estimated $823K trimmed.

  • Banco de Sabadell's largest Q4 2023 buy was Amgen: 7,816 shares worth $2.25M.
  • Banco de Sabadell added most to Pfizer in Q4 2023, an estimated $1.05M increase.
  • Banco de Sabadell's biggest Q4 2023 reduction was Microsoft, cutting an estimated $823K.
  • Banco de Sabadell fully exited Baxter International in Q4 2023, selling an estimated $599K.
  • Banco de Sabadell's ten largest holdings make up 31% of its $132M portfolio in Q4 2023.
  • Banco de Sabadell opened 3 new positions and closed 3 in Q4 2023.
  • Banco de Sabadell's portfolio value rose 14% quarter-over-quarter to $132M.

Based on Banco de Sabadell's 13F filing for Q4 2023, filed 9 Feb 2024.